

浏览全部资源
扫码关注微信
1.中国中医科学院 中药研究所,道地药材与品质保障全国重点实验室,北京 100700
2.中国中医科学院 青蒿素研究中心,北京 100700
Received:01 August 2024,
Accepted:11 September 2024,
Published Online:08 October 2024,
Published:05 December 2024
移动端阅览
李玉洁,刘拓,王璐琪等.符合中医药特点的中药药效评价创新方法: 基于五脏关联规律的中药复方“同治/同调”药效优势表征体系构建思考[J].中国实验方剂学杂志,2024,30(23):19-26.
LI Yujie,LIU Tuo,WANG Luqi,et al.Innovation of Methods for Efficacy Evaluation of Traditional Chinese Medicine Compound Prescriptions: Establishment of Characterization System for Simultaneous Treatment/Regulation Based on Correlation Patterns of Five Zang-organs[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(23):19-26.
李玉洁,刘拓,王璐琪等.符合中医药特点的中药药效评价创新方法: 基于五脏关联规律的中药复方“同治/同调”药效优势表征体系构建思考[J].中国实验方剂学杂志,2024,30(23):19-26. DOI: 10.13422/j.cnki.syfjx.20250393.
LI Yujie,LIU Tuo,WANG Luqi,et al.Innovation of Methods for Efficacy Evaluation of Traditional Chinese Medicine Compound Prescriptions: Establishment of Characterization System for Simultaneous Treatment/Regulation Based on Correlation Patterns of Five Zang-organs[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(23):19-26. DOI: 10.13422/j.cnki.syfjx.20250393.
中药复方临床疗效优势在实验研究中始终无法得以充分表征,成为制约中药药理学乃至中医药发展的瓶颈问题。五脏生克制化理论指导下的“同治/同调”思想,在历代中医临床中有重要指导意义,且仍广泛应用于当代临床。但这一独特而极具临床价值的辨治用药体系,在现代中药药理学研究中被完全忽视,可能是制约中药复方疗效优势药理学表征的关键因素之一。该文在系统总结中药复方药效评价阶段性研究进展和成就基础上,从“藏象”与五脏核心观、基于五脏“生克制化”的中医疾病认识观等方面,思考基于中医五脏关联规律的中药复方“同治/同调”药效优势挖掘路径,并以心肺关系为切入点,以“心肺同治”为范例,思考中药药效优势的药理学表征新方法,以期为中药复方药效评价方法学突破提供新的思路。
The clinical efficacy advantages of traditional Chinese medicine (TCM) compound prescriptions have always been inadequately characterized in experimental research,which has become a bottleneck restricting the development of TCM pharmacology and even the progress of TCM. The concept of simultaneous treatment/regulation,guided by the theory of mutual generation and restriction of five zang-organs,has guiding significance in the clinical practice of TCM throughout history and is still widely used in the current clinical practice. However,this unique and clinically valuable diagnostic and therapeutic medication system based on the syndrome differentiation has been completely ignored in the modern research of TCM pharmacology,which might be one of the key factors restricting the pharmacological characterization of the therapeutic advantages of TCM compound prescriptions. On the basis of systematically summarizing the phased progress and achievements of the efficacy evaluation of TCM compound prescriptions,this article explores the path of exploring the pharmacological advantages of TCM compound prescriptions on simultaneous treatment/regulation on the basis of the correlation patterns of five zang-organs,from the theory of Zangxiang,the core concept of five zang-organs,and the TCM disease recognition based on the theory of mutual generation and restriction of five zang-organs. With the heart-lung correlation as a breakthrough point,this study explored a new characterization method for the pharmacological advantages of TCM,aiming to provide new ideas for evaluating the efficacy of TCM compound prescriptions.
刘建勋 , 孙明谦 , 任钧国 , 等 . 中药复方功效物质基础的研究思路与方法 [J]. 世界科学技术—中医药现代化 , 2018 , 20 ( 4 ): 473 - 478 .
刘建勋 , 任建勋 , 林成仁 . 中药复方功效的研究与发展 [J]. 中国中药杂志 , 2016 , 41 ( 6 ): 971 - 975 .
田赛赛 , 杨健 , 赵静 , 等 . 网络生物学在中医药研究中的应用 [J]. 中国中药杂志 , 2018 , 43 ( 2 ): 274 - 280 .
YUAN X , HAN L , FU P , et al . Cinnamaldehyde accelerates wound healing by promoting angiogenesis via up-regulation of PI3K and MAPK signaling pathways [J]. Lab Invest , 2018 , 98 ( 6 ): 783 - 798 .
WANG X , ZHANG A , SUN H . Future perspectives of Chinese medical formulae:Chinmedomics as an effector [J]. OMICS , 2012 , 16 ( 7-8 ): 414 - 421 .
张爱华 , 孙晖 , 闫广利 , 等 . 中药有效性评价与药效物质基础发现 [J]. 世界科学技术—中医药现代化 , 2016 , 18 ( 5 ): 719 - 723 .
谌攀 , 吴博文 , 张鹏 , 等 . 基于生物网络的中医药学原理探索 [J]. 科学通报 , 2024 , 69 ( 1 ): 17 - 29 .
WANG X , WU M , LAI X , et al . Network pharmacology to uncover the biological basis of spleen Qi deficiency syndrome and herbal treatment [J]. Oxid Med Cell Longev , 2020 , 2020 : 2974268 .
ZHANG P , ZHANG D , ZHOU W , et al . Network pharmacology:Towards the artificial intelligence-based precision traditional Chinese medicine [J]. Brief Bioinform , 2023 , 25 ( 1 ): bbad518 .
许海玉 , 杨洪军 . 整合药理学:中药现代研究新模式 [J]. 中国中药杂志 , 2014 , 39 ( 3 ): 357 - 362 .
XU H , LI S , LIU J , et al . Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19 [J]. Proc Natl Acad Sci U S A , 2023 , 120 ( 18 ): e2301775120 .
肖小河 , 罗烨 , 赵旭 , 等 . 中药有效性评价新策略新方法:整合证据链法 [J/OL]. 中国中药杂志 , 1 - 12 .( 2024-07-11 )[ 2024-07-31 ]. https://doi.org/10.19540/j.cnki.cjcmm.20240709.601 https://doi.org/10.19540/j.cnki.cjcmm.20240709.601 .
徐志伟 , 刘小斌 , 邱仕君 , 等 . 中医"五脏相关"理论继承与创新的初步研究 [J]. 广州中医药大学学报 , 2008 , 25 ( 6 ): 475 - 479 .
刘小斌 . 邓铁涛教授"五脏相关"学术源流探讨 [J]. 广州中医药大学学报 , 2006 , 23 ( 5 ): 424 - 427 .
郑洪 . 五脏相关学说理论研究与临床分析 [D]. 广州 : 广州中医药大学 , 2002 .
颜彦 . 心肺脏理论源流考 [D]. 上海 : 上海中医药大学 , 2019 .
VERHOEFF K , MITCHELL J R . Cardiopulmonary physiology:Why the heart and lungs are inextricably linked [J]. Adv Physiol Educ , 2017 , 41 ( 3 ): 348 - 353 .
杨晓 , 李小娟 . 心肺同治理论在临床中应用进展 [J]. 中医研究 , 2021 , 34 ( 1 ): 50 - 53 .
徐梦娇 , 晏军 , 张迪 , 等 . 中医药多靶点治疗慢性阻塞性肺疾病机制的研究概论 [J]. 世界中医药 , 2023 , 18 ( 16 ): 2396 - 2401 .
吴华芹 , 王新建 , 胡元会 . “从肺论治”心力衰竭经验探析 [J]. 中西医结合心脑血管病杂志 , 2018 , 16 ( 18 ): 2736 - 2738 .
杨娟 , 曹敏 , 苑素云 . 基于心肺同治法应用参蛤散治疗慢性心力衰竭 [J]. 天津中医药 , 2019 , 36 ( 1 ): 27 - 30 .
胡晓玲 , 安静 , 吴海斌 , 等 . 基于心肺同治理论应用益气化痰活血方治疗慢性肺源性心脏病合并冠心病气虚痰瘀互结证的临床观察 [J]. 中华中医药杂志 , 2019 , 34 ( 7 ): 3323 - 3326 .
WANG D , HU B , HU C , et al . Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan,China [J]. JAMA , 2020 , 323 ( 11 ): 1061 - 1069 .
GU Z C , ZHANG C , KONG L C , et al . Incidence of myocardial injury in coronavirus disease 2019 (COVID-19):A pooled analysis of 7,679 patients from 53 studies [J]. Cardiovasc Diagn Ther , 2020 , 10 ( 4 ): 667 - 677 .
咸楠星 , 张哲 , 李宁 , 等 . 基于新型冠状病毒肺炎病因与病机传变规律探讨重症患者从心论治 [J]. 中华中医药学刊 , 2020 , 38 ( 4 ): 20 - 24 .
孙怿泽 , 王哲义 , 侯季秋 , 等 . 从“逆传心包”角度认识新型冠状病毒肺炎相关心脏并发症 [J]. 世界中医药 , 2020 , 15 ( 4 ): 529 - 532 .
PURI G , SINGH V P , NAURA A S . COVID-19 severity:Lung-heart interplay [J]. Curr Cardiol Rev , 2021 , 17 ( 4 ): e230421189016 .
《中国心血管健康与疾病报告》编写组 . 《中国心血管健康与疾病报告2020》要点解读 [J]. 中国心血管杂志 , 2021 , 26 ( 3 ): 209 - 218 .
国家心血管病中心空气污染与心血管疾病专家共识组 . 空气污染与心血管疾病专家共识 [J]. 中国循环杂志 , 2021 , 36 ( 1 ): 14 - 21 .
LI J , LIU F , LIANG F , et al . Long-term effects of high exposure to ambient fine particulate matter on coronary heart disease incidence:A population-based chinese cohort study [J]. Environ Sci Technol , 2020 , 54 ( 11 ): 6812 - 6821 .
ZHANG Y , MA R , BAN J , et al . Risk of cardiovascular hospital admission after exposure to fine particulate pollution [J]. J Am Coll Cardiol , 2021 , 78 ( 10 ): 1015 - 1024 .
AL-KINDI S G , BROOK R D , BISWAL S , et al . Environmental determinants of cardiovascular disease:lessons learned from air pollution [J]. Nat Rev Cardiol , 2020 , 17 ( 10 ): 656 - 672 .
WU S , CHEN Z , YANG L , et al . Particle-bound PAHs induced glucose metabolism disorders through HIF-1 pathway [J]. Sci Total Environ , 2021 , 797 : 149132 .
HABERZETTL P , JIN L , RIGGS D W , et al . Fine particulate matter air pollution and aortic perivascular adipose tissue:Oxidative stress,leptin,and vascular dysfunction [J]. Physiol Rep , 2021 , 9 ( 15 ): e14980 .
CHEN Y , HU K , BU H , et al . Probucol protects circulating endothelial progenitor cells from ambient PM 2.5 damage via inhibition of reactive oxygen species and inflammatory cytokine production in vivo [J]. Exp Ther Med , 2018 , 16 ( 6 ): 4322 - 4328 .
0
Views
100
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621